[1]
Kulkarni, P. and Menon, S. 2023. A randomized open-label study to compare iron content in the blood of healthy subjects treated with Tasiron tablets containing ferric di-phosphate as compared to tablets containing ferrous ascorbate. International Journal of Advances in Medicine. 10, 12 (Nov. 2023), 836–839. DOI:https://doi.org/10.18203/2349-3933.ijam20233567.